These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23564636)

  • 1. Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis.
    Vilaplana C; Marzo E; Tapia G; Diaz J; Garcia V; Cardona PJ
    J Infect Dis; 2013 Jul; 208(2):199-202. PubMed ID: 23564636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longer-Term Omega-3 LCPUFA More Effective Adjunct Therapy for Tuberculosis Than Ibuprofen in a C3HeB/FeJ Tuberculosis Mouse Model.
    Hayford FEA; Ozturk M; Dolman RC; Blaauw R; Nienaber A; Loots DT; Brombacher F; Smuts CM; Parihar SP; Malan L
    Front Immunol; 2021; 12():659943. PubMed ID: 33995381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Damaging role of neutrophilic infiltration in a mouse model of progressive tuberculosis.
    Marzo E; Vilaplana C; Tapia G; Diaz J; Garcia V; Cardona PJ
    Tuberculosis (Edinb); 2014 Jan; 94(1):55-64. PubMed ID: 24291066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis.
    Byrne ST; Denkin SM; Zhang Y
    J Antimicrob Chemother; 2007 Feb; 59(2):313-6. PubMed ID: 17185297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal antiinflammatory drugs for adjunctive tuberculosis treatment.
    Ivanyi J; Zumla A
    J Infect Dis; 2013 Jul; 208(2):185-8. PubMed ID: 23564637
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose aspirin and ibuprofen's sterilizing effects on Mycobacterium tuberculosis suggest safe new adjuvant therapies for tuberculosis.
    Eisen DP; McBryde ES; Walduck A
    J Infect Dis; 2013 Dec; 208(11):1925-7. PubMed ID: 23997233
    [No Abstract]   [Full Text] [Related]  

  • 7. Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis.
    Lanoix JP; Lenaerts AJ; Nuermberger EL
    Dis Model Mech; 2015 Jun; 8(6):603-10. PubMed ID: 26035868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of multiple lesion types with vastly different microenvironments in C3HeB/FeJ mice following aerosol infection with Mycobacterium tuberculosis.
    Irwin SM; Driver E; Lyon E; Schrupp C; Ryan G; Gonzalez-Juarrero M; Basaraba RJ; Nuermberger EL; Lenaerts AJ
    Dis Model Mech; 2015 Jun; 8(6):591-602. PubMed ID: 26035867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Course of murine tuberculosis and response to first-line therapy depends on route of infection and inoculum size.
    de Steenwinkel JE; ten Kate MT; de Knegt GJ; Verbrugh HA; van Belkum A; Hernandez-Pando R; Bakker-Woudenberg IA
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1478-84, i. PubMed ID: 22008760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice.
    Dutta NK; Mazumdar K; Dastidar SG; Park JH
    Int J Antimicrob Agents; 2007 Oct; 30(4):336-40. PubMed ID: 17644321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abatacept treatment does not exacerbate chronic Mycobacterium tuberculosis infection in mice.
    Bigbee CL; Gonchoroff DG; Vratsanos G; Nadler SG; Haggerty HG; Flynn JL
    Arthritis Rheum; 2007 Aug; 56(8):2557-65. PubMed ID: 17665452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of IQG-607, a new orally active compound, in a murine model of Mycobacterium tuberculosis infection.
    Rodrigues-Junior VS; Dos Santos Junior A; Dos Santos AJ; Schneider CZ; Calixto JB; Sousa EH; de França Lopes LG; Souto AA; Basso LA; Santos DS; Campos MM
    Int J Antimicrob Agents; 2012 Aug; 40(2):182-5. PubMed ID: 22748570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug distribution and efficacy of the DprE1 inhibitor BTZ-043 in the C3HeB/FeJ mouse tuberculosis model.
    Ramey ME; Kaya F; Bauman AA; Massoudi LM; Sarathy JP; Zimmerman MD; Scott DWL; Job AM; Miller-Dawson JA; Podell BK; Lyons MA; Dartois V; Lenaerts AJ; Robertson GT
    Antimicrob Agents Chemother; 2023 Nov; 67(11):e0059723. PubMed ID: 37791784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium tuberculosis persistence in various adipose depots of infected mice and the effect of anti-tubercular therapy.
    Agarwal P; Khan SR; Verma SC; Beg M; Singh K; Mitra K; Gaikwad AN; Akhtar MS; Krishnan MY
    Microbes Infect; 2014 Jul; 16(7):571-80. PubMed ID: 24819214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
    Lu J; Yue J; Wu J; Luo R; Hu Z; Li J; Bai Y; Tang Z; Xian Q; Zhang X; Wang H
    Pharmacology; 2010; 85(6):365-71. PubMed ID: 20530976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix Metalloproteinase Inhibition in a Murine Model of Cavitary Tuberculosis Paradoxically Worsens Pathology.
    Ordonez AA; Pokkali S; Sanchez-Bautista J; Klunk MH; Urbanowski ME; Kübler A; Bishai WR; Elkington PT; Jain SK
    J Infect Dis; 2019 Jan; 219(4):633-636. PubMed ID: 29920600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapses after stopping chemotherapy for experimental tuberculosis in genetically resistant and susceptible strains of mice.
    Lecoeur HF; Lagrange PH; Truffot-Pernot C; Gheorghiu M; Grosset J
    Clin Exp Immunol; 1989 Jun; 76(3):458-62. PubMed ID: 2502336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sterilizing activity of R207910 (TMC207)-containing regimens in the murine model of tuberculosis.
    Ibrahim M; Truffot-Pernot C; Andries K; Jarlier V; Veziris N
    Am J Respir Crit Care Med; 2009 Sep; 180(6):553-7. PubMed ID: 19590024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activities of clofazimine against Mycobacterium tuberculosis in vitro and in vivo].
    Lu Y; Zheng MQ; Wang B; Zhao WJ; Li P; Chu NH; Liang BW
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Oct; 31(10):752-5. PubMed ID: 19080601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.